Form 4: Achieve Life Sciences Director, Nancy R. Phelan, Granted Stock Options

Director Nancy R. Phelan of Achieve Life Sciences, Inc. was granted stock options to purchase 47,250 shares of common stock.

Summary

• On January 13, 2025, Nancy R. Phelan, a director of Achieve Life Sciences, Inc. (ACHV), was granted stock options.
• These options allow her to purchase 47,250 shares of the company's common stock at an exercise price of $3.32 per share.
• The options vest in equal monthly installments over 36 months, starting January 6, 2025, contingent on her continued service to the company.
• The options expire on January 13, 2035.

Sentiment

Score: 7

Explanation: The document itself is neutral, simply reporting a transaction. However, the granting of stock options to a director is generally viewed positively as it aligns interests and incentivizes performance.

Positives

• The granting of stock options to a director aligns her interests with those of the shareholders, incentivizing her to work towards the company's success.
• The vesting schedule encourages long-term commitment from the director.

Future Outlook

The document does not contain specific forward-looking statements about the company's future performance, but the granting of stock options suggests an expectation of future growth and value creation.

Industry Context

Stock options are a common form of executive compensation in the biotechnology industry, used to attract and retain talent and align their interests with those of shareholders. This grant is typical for directors in similar companies.

Comparison to Industry Standards

• Stock option grants to directors are a standard practice in publicly traded companies, particularly in the biotech sector.
• The size of the grant (47,250 shares) and the vesting schedule (36 months) appear to be within the typical range for director compensation at companies of similar size and stage of development as Achieve Life Sciences.
• Comparable companies like CymaBay Therapeutics or Galectin Therapeutics also utilize stock options as part of their director compensation packages.

Stakeholder Impact

• Shareholders may view the granting of stock options positively as it aligns the director's interests with theirs.
• The director is incentivized to contribute to the company's success to increase the value of her options.

Key Dates